ISSN: 1759-5029

Journal Home

Journal Guideline

Nature Reviews Endocrinology Q1 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Nature Reviews Endocrinology is a journal indexed in SJR in Endocrinology and Endocrinology, Diabetes and Metabolism with an H index of 187. It has an SJR impact factor of 8,124 and it has a best quartile of Q1. It has an SJR impact factor of 8,124.

Nature Reviews Endocrinology focuses its scope in these topics and keywords: insulin, d, gut, lipid, health, exercise, metabolic, marrow, glucose, diabetes, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Endocrinology (Q1) Endocrinology, Diabetes and Metabolism (Q1) Endocrinology, Diabetes and Metabolism (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

8,124

SJR Impact factor

187

H Index

174

Total Docs (Last Year)

450

Total Docs (3 years)

7974

Total Refs

6747

Total Cites (3 years)

203

Citable Docs (3 years)

12.99

Cites/Doc (2 years)

45.83

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Diabetes and Endocrinology Q1
Endocrine Reviews Q1
Nature Metabolism Q1
Diabetes Care Q1
Diabetologia Q1

Compare this journals

Aims and Scope

Best articles by citations

Malformation syndromes associated with disorders of sex development

Can inflammatory status define metabolic health?

Gut-specific FXR agonism

Late to bed, late to rise, could be cardiometabolically unwise

Does celiac disease trigger autoimmune thyroiditis?

Should we screen for emotional distress in type 2 diabetes mellitus?

Safety and efficacy of albiglutide - results from two trials

Balancing BMI - rethinking the relationships between obesity, ageing and risk of dementia

Hypertension in obesity: the role of hypothalamic inflammation

Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism

Postablative thyroglobulin levels predict recurrence of thyroid cancer

A conundrum addressed: the prognostic value of HbA1c

SHOW MORE ARTICLES

Testosterone replacement therapy improves the metabolic syndrome

Outcomes of diabetes mellitus in Asian Americans

Not so sweet - artificial sweeteners can cause glucose intolerance by affecting the gut microbiota

Impact loading - nature's way to strengthen bone

Epigenetic changes lead to impaired wound healing in patients with T2DM

T2DM - PPAR gamma ligands without the adverse effects?

Formation of blood vessels in bone maturation and regeneration

Predictors of metabolic outcome after surgery for adrenal incidentaloma

Reversing the tide - diagnosis and prevention of T2DM in populations of African descent

Osteopontin to determine response to parathyroid hormone therapy?

ILC2s regulate obesity and drive beiging of white adipose tissue

A role for CFTR in beta-cell function